Proto Labs (PRLB)
(Delayed Data from NYSE)
$29.44 USD
+0.82 (2.87%)
Updated Jan 27, 2023 04:00 PM ET
After-Market: $29.42 -0.02 (-0.07%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$29.44 USD
+0.82 (2.87%)
Updated Jan 27, 2023 04:00 PM ET
After-Market: $29.42 -0.02 (-0.07%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum D VGM
Zacks News
Proto Labs (PRLB) Tops Q3 Earnings Estimates
by Zacks Equity Research
Proto Labs (PRLB) delivered earnings and revenue surprises of 5.26% and 2.69%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Trinseo (TSE) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trinseo (TSE) delivered earnings and revenue surprises of -14.57% and 6.33%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
5 Top Stocks to Buy on New Analysts' Coverage
by Shrabana Mukherjee
Increased analyst coverage over the past few weeks may lead to solid price appreciation for stocks like Napco Security (NSSC), Proto Labs (PRLB), Clear Secure (YOU), AVEO and Mind Medicine (MNMD).
Down 25.4% in 4 Weeks, Here's Why Proto Labs (PRLB) Looks Ripe for a Turnaround
by Zacks Equity Research
Proto Labs (PRLB) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Analysts Initiate Coverage: 5 Stocks to Buy for Higher Returns
by Shrabana Mukherjee
Increased analyst coverage over the past few weeks may lead to solid price appreciation for stocks like Professional Holding (PFHD), Trinity (TRIN), SunOpta (STKL), Arcos Dorados (ARCO) and Proto Labs (PRLB).
Here's Why Proto Labs (PRLB) Could be Great Choice for a Bottom Fisher
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for Proto Labs (PRLB), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Proto Labs (PRLB) Tops Q2 Earnings Estimates
by Zacks Equity Research
Proto Labs (PRLB) delivered earnings and revenue surprises of 21.05% and 0.46%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Proto Labs (PRLB) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Proto Labs (PRLB) delivered earnings and revenue surprises of 35.71% and 2.51%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Proto Labs (PRLB) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Proto Labs (PRLB) delivered earnings and revenue surprises of 41.38% and 5.63%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Proto Labs (PRLB) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Proto Labs (PRLB) delivered earnings and revenue surprises of -12.50% and -2.03%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Proto Labs (PRLB) Q3 Earnings Expected to Decline
by Zacks Equity Research
Proto Labs (PRLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for September 21st
by Zacks Equity Research
FRO, NTES, GPRK, RXT, and PRLB have been added to the Zacks Rank #5 (Strong Sell) List on September 21, 2021
Proto Labs (PRLB) Misses Q2 Earnings Estimates
by Zacks Equity Research
Proto Labs (PRLB) delivered earnings and revenue surprises of -15.22% and 0.90%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Proto Labs (PRLB) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Proto Labs (PRLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for May 20th
by Zacks Equity Research
AXDX, CRIS, FSTR, GO, and PRLB have been added to the Zacks Rank #5 (Strong Sell) List on May 20, 2021
Proto Labs (PRLB) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Proto Labs (PRLB) delivered earnings and revenue surprises of 8.11% and 3.04%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Proto Labs (PRLB) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Proto Labs (PRLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Proto Labs (PRLB) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Proto Labs (PRLB) delivered earnings and revenue surprises of 4.17% and 2.56%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Proto Labs (PRLB) Q4 Earnings Expected to Decline
by Zacks Equity Research
Proto Labs (PRLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for February 1st
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Will Proto Labs (PRLB) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Proto Labs (PRLB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Proto Labs (PRLB) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Proto Labs (PRLB) delivered earnings and revenue surprises of 31.37% and 4.58%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Proto Labs (PRLB) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Proto Labs (PRLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: General Motors, Tesla, 3D Systems, Materialise and Proto Labs
by Zacks Equity Research
The Zacks Analyst Blog Highlights: General Motors, Tesla, 3D Systems, Materialise and Proto Labs
The Innovative Future Of ETFs
by Daniel Laboe
Ark Invest is driving a new generation of actively managed ETFs